NYSE:AVNSAvanos Medical Stock Price, Forecast & News

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVNS stock has increased by 4.6% and is now trading at $30.34. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Avanos Medical.

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Avanos Medical.

Avanos Medical Inc (NYSE:AVNS) issued its quarterly earnings results on Wednesday, May, 6th. The company reported $0.16 earnings per share for the quarter, meeting analysts' consensus estimates of $0.16. The firm earned $180.40 million during the quarter, compared to the consensus estimate of $175.15 million. Avanos Medical had a positive return on equity of 4.09% and a negative net margin of 3.07%. Avanos Medical's revenue for the quarter was up 9.9% on a year-over-year basis. During the same period last year, the business earned $0.15 earnings per share. View Avanos Medical's earnings history.

7 equities research analysts have issued 12 month target prices for Avanos Medical's stock. Their forecasts range from $30.00 to $48.00. On average, they anticipate Avanos Medical's share price to reach $36.00 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price. View analysts' price targets for Avanos Medical.

Media coverage about AVNS stock has trended somewhat negative recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avanos Medical earned a news impact score of -1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Avanos Medical.

Avanos Medical saw a decrease in short interest in June. As of June 15th, there was short interest totaling 2,370,000 shares, a decrease of 13.8% from the May 31st total of 2,750,000 shares. Based on an average daily volume of 430,000 shares, the days-to-cover ratio is currently 5.5 days. Approximately 5.1% of the company's shares are short sold. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wright Medical Group (WMGI), Wound Management Technologies (WNDM), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), ConforMIS (CFMS), Allied Healthcare Products (AHPI), Histogenics (HSGX), Rewalk Robotics (RWLK) and Precision Therapeutics (POAI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), AT&T (T), Alibaba Group (BABA), CVS Health (CVS), Honeywell International (HON), Procter & Gamble (PG), Verizon Communications (VZ), Home Depot (HD), Johnson & Johnson (JNJ) and Altria Group (MO).

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (1.16%). Company insiders that own Avanos Medical stock include Gary Blackford, John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View institutional ownership trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC. View insider buying and selling activity for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $30.34.

Avanos Medical has a market capitalization of $1.45 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

The official website for Avanos Medical is avanos.com.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]